Recent News

• 02.07.2025 - Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 01.06.2025 - Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)
• 12.03.2024 - Piper Sandler 36th Annual Healthcare Conference
• 11.25.2024 - Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference
• 11.12.2024 - Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Recent Filings

• 02.06.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.27.2025 - EFFECT Notice of Effectiveness
• 01.24.2025 - S-3/A Registration statement under Securities Act of 1933
• 01.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.31.2024 - 8-K Current report